Harford Simon N.R. 4
4 · ALBIREO PHARMA, INC. · Filed Jan 20, 2023
Insider Transaction Report
Form 4
Harford Simon N.R.
CFO and Treasurer
Transactions
- Sale
Common Stock
2023-01-19$43.80/sh−1,776$77,789→ 32,791 total
Footnotes (2)
- [F1]Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
- [F2]Represents 13,497 shares of common stock and 19,294 restricted stock units. Includes 1,272 shares of common stock acquired under the Albireo Pharma, Inc. 2018 Employee Stock Purchase Plan (the "ESPP") on November 30, 2022.